Cytogen, Inc. (KOSDAQ:217330)
South Korea · Delayed Price · Currency is KRW 2,980.00
+35.00 (1.19%)
At close: Jul 21, 2026
Cytogen Market Cap
Cytogen has a market cap or net worth of 68.75 billion as of July 21, 2026. Its market cap has decreased by -0.33% in one year.
Market Cap
68.75B
Enterprise Value
59.59B
Revenue
26.84B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,980.00
ChartMarket Cap Chart
Since November 22, 2018, Cytogen's market cap has decreased from 87.89B to 68.75B, a decrease of -21.78%. That is a compound annual growth rate of -3.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 68.75B | -66.85% |
| Dec 30, 2025 | 207.40B | 98.24% |
| Dec 30, 2024 | 104.62B | -59.34% |
| Dec 28, 2023 | 257.28B | -11.12% |
| Dec 29, 2022 | 289.47B | -18.62% |
| Dec 30, 2021 | 355.72B | 47.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dx & Vx | 210.64B |
| 3billion | 171.52B |
| GENINUS | 80.95B |
| Protia | 63.18B |
| GC Medical Science | 57.18B |
| Inventera | 55.53B |
| HLB Panagene | 48.44B |
| Seoulin Bioscience | 39.33B |